Compare AXTI & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AXTI | MMSI |
|---|---|---|
| Founded | 1986 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 4.0B |
| IPO Year | 1998 | 1996 |
| Metric | AXTI | MMSI |
|---|---|---|
| Price | $77.39 | $69.94 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | $24.50 | ★ $99.13 |
| AVG Volume (30 Days) | ★ 12.8M | 575.3K |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 4.93 |
| EPS | N/A | ★ 2.13 |
| Revenue | $99,361,000.00 | ★ $1,515,906,000.00 |
| Revenue This Year | $44.70 | $8.85 |
| Revenue Next Year | $42.23 | $5.88 |
| P/E Ratio | ★ N/A | $33.29 |
| Revenue Growth | ★ 31.09 | 11.75 |
| 52 Week Low | $1.20 | $66.34 |
| 52 Week High | $83.25 | $99.26 |
| Indicator | AXTI | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 63.33 | 48.07 |
| Support Level | $5.52 | $66.76 |
| Resistance Level | N/A | $71.57 |
| Average True Range (ATR) | 9.68 | 1.77 |
| MACD | 1.90 | 0.59 |
| Stochastic Oscillator | 86.54 | 63.58 |
AXT Inc is a developer and producer of compound and single element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.